Product Detail
α-Thujene-d3
Stable Isotope Reagent
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotope Reagent
API Family
--
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
α-Thujene-d3 Product Information
α-Thujene-d3 is listed under Stable Isotope Reagent. It is associated with - and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-103563.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
α-Thujene-d3
CAS No.
2867-05-2 (Unlabelled)
CAT No.
CS-T-103563
Molecular Formula
C₁₀H₁₃D₃
Molecular Weight
139.25
Category
API Family
Storage Condition
Refer MSDS for complete information.
IUPAC Name
3-Thujene-d3; 2-Methyl-5-(1-methylethyl)bicyclo[3.1.0]hex-2-ene-d3; (±)-α-Thujene-d3; 2-Methyl-5-isopropylbicyclo[3.1.0]-2-hexene; Origanene-d3; 2-Methyl-5-(1-methylethyl)-bicyclo[3.1.0]hex-2-ene-d3
Hazard Compound
Refer MSDS for complete information.
Description
Overview
α-Thujene-d3 is deuterium labelled α-Thujene (T405800). α-Thujene can be isolated from Teucrium ramosissimum and Eucalyptus citriodora Hook. (Myrtaceae). It also exhibit antioxidant and anticancer activities against human tumor cells (hepatocellular carcinoma (liver) HePG-2, mammary gland (breast) MCF-7 and colorectal carcinoma (colon) HCT-116).
Synonyms
3-Thujene-d3; 2-Methyl-5-(1-methylethyl)bicyclo[3.1.0]hex-2-ene-d3; (±)-α-Thujene-d3; 2-Methyl-5-isopropylbicyclo[3.1.0]-2-hexene; Origanene-d3; 2-Methyl-5-(1-methylethyl)-bicyclo[3.1.0]hex-2-ene-d3
Application Notes
α-Thujene-d3 is deuterium labelled α-Thujene (T405800). α-Thujene can be isolated from Teucrium ramosissimum and Eucalyptus citriodora Hook. (Myrtaceae). It also exhibit antioxidant and anticancer activities against human tumor cells (hepatocellular carcinoma (liver) HePG-2, mammary gland (breast) MCF-7 and colorectal carcinoma (colon) HCT-116).
References
Ghazouani, N., et al.: Anal. Lett. 49, 1258 (2016); Ghareeb, M. A., et al.: Pharma Chemica 8, 192 (2016)
